183 related articles for article (PubMed ID: 36814156)
1. MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m
Li X; Liu B; Wang S; Li J; Ge X
Chin J Physiol; 2023; 66(1):43-51. PubMed ID: 36814156
[TBL] [Abstract][Full Text] [Related]
2. Arginine methylation of ALKBH5 by PRMT6 promotes breast tumorigenesis via LDHA-mediated glycolysis.
Han X; Ren C; Jiang A; Sun Y; Lu J; Ling X; Lu C; Yu Z
Front Med; 2024 Apr; 18(2):344-356. PubMed ID: 38466502
[TBL] [Abstract][Full Text] [Related]
3. The N
Li Z; Wang P; Li J; Xie Z; Cen S; Li M; Liu W; Ye G; Zheng G; Ma M; Wang S; Yu W; Wu Y; Shen H
Cell Death Dis; 2021 Jun; 12(6):578. PubMed ID: 34088896
[TBL] [Abstract][Full Text] [Related]
4.
Zhao X; Zhao Z; Xie H; Gao W; Ye C
Discov Med; 2024 Jan; 36(180):61-70. PubMed ID: 38273746
[TBL] [Abstract][Full Text] [Related]
5. A positive feedback loop between AlkB homolog 5 and miR-193a-3p promotes growth and metastasis in esophageal squamous cell carcinoma.
Xue J; Xiao P; Yu X; Zhang X
Hum Cell; 2021 Mar; 34(2):502-514. PubMed ID: 33231844
[TBL] [Abstract][Full Text] [Related]
6. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
[TBL] [Abstract][Full Text] [Related]
7. ALKBH5 promotes the progression of infantile hemangioma through regulating the NEAT1/miR-378b/FOSL1 axis.
Peng K; Xia RP; Zhao F; Xiao Y; Ma TD; Li M; Feng Y; Zhou CG
Mol Cell Biochem; 2022 May; 477(5):1527-1540. PubMed ID: 35182329
[TBL] [Abstract][Full Text] [Related]
8. ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1.
Sun W; Li Y; Ma D; Liu Y; Xu Q; Cheng D; Li G; Ni C
Cell Mol Biol Lett; 2022 Mar; 27(1):26. PubMed ID: 35279083
[TBL] [Abstract][Full Text] [Related]
9. m
Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
[TBL] [Abstract][Full Text] [Related]
10. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W
Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004
[TBL] [Abstract][Full Text] [Related]
11. ALKBH5 activates FAK signaling through m6A demethylation in
Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
[No Abstract] [Full Text] [Related]
12. ALKBH5-mediated m6A demethylation of pri-miR-199a-5p exacerbates myocardial ischemia/reperfusion injury by regulating TRAF3-mediated pyroptosis.
Li J; Wang Z; Tan H; Tang M
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23710. PubMed ID: 38605440
[TBL] [Abstract][Full Text] [Related]
13. The circSPON2/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression.
Yao B; Zhu S; Wei X; Chen MK; Feng Y; Li Z; Xu X; Zhang Y; Wang Y; Zhou J; Tang N; Ji C; Jiang P; Zhao SC; Qin C; Feng N
Mol Cancer; 2022 May; 21(1):119. PubMed ID: 35624451
[TBL] [Abstract][Full Text] [Related]
14. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
Pan MZ; Song YL; Gao F
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
[TBL] [Abstract][Full Text] [Related]
15. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
[TBL] [Abstract][Full Text] [Related]
16. HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.
Huo FC; Zhu ZM; Du WQ; Pan YJ; Jiang X; Kang MJ; Liu BW; Mou J; Pei DS
Pharmacol Res; 2023 Sep; 195():106863. PubMed ID: 37480971
[TBL] [Abstract][Full Text] [Related]
17. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
[TBL] [Abstract][Full Text] [Related]
18. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
[TBL] [Abstract][Full Text] [Related]
19. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
20. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
